ACTRN12615001238561已完成未知
To determine the feasibility of cardiac MRI, echocardiography and serum biomarkers in detecting both early and later cardiac dysfunction in cancer patients after exposure to chemotherapy and/or radiotherapy.
iverpool Hospital0 个研究点目标入组 44 人开始时间: 2015年11月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 44
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Diagnosis
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit(—)
- 性别
- All
入选标准
- •Cohort A – breast cancer patients
- •(i) Aged greater than or equal to 18 years or older
- •(ii) Histologically confirmed diagnosis of invasive breast carcinoma
- •(iii) Receiving any anthracycline-containing breast cancer treatment regimen, including any adjuvant trastuzumab therapy AND going on to receive adjuvant left breast +/- loco-regional nodal radiotherapy, OR
- •(iv) Receiving adjuvant left breast +/- loco-regional nodal radiotherapy alone (without chemotherapy).
- •Acceptable radiotherapy regimens for Cohort A patients include:
- •a)50Gy in 25 daily fractions +/- 10-16Gy tumour bed boost, over 5-6 weeks
- •b)42.4Gy in 16 daily fractions +/- 10Gy tumour bed boost, over 3-4 weeks
- •Cohort B – Non Hodgkin (NHL) Hodgkin lymphoma (HL) and leukaemia patients
- •(i) Aged greater than or equal to 18 years or older
- •(ii) Histologically confirmed diagnosis of lymphoma
- •(iii) Receiving any anthracycline-or alkylator-containing chemotherapy regimen (eg. R-CHOP for NHL patients and ABVD for HL patients) and/or
- •(iv) Receiving definitive or adjuvant (post-chemotherapy) radiotherapy (dose greater than or equal to 20Gy) encompassing the mediastinum (ie. including cardiac structures)
- •Acceptable radiotherapy regimens for Cohort B patients include:
- •*Dose ranges from 20-40Gy in 1.5-2Gy daily fractions, over 2-4 weeks
- •Cohort C – other intra-thoracic/upper gastrointestinal malignancy patients (eg oesophageal/other eg thymoma)
- •(i) Aged greater than or equal to 18 years or older
- •(ii) Histologically confirmed intra-thoracic or upper gastrointestinal malignancy
- •(iii)Receiving any neoadjuvant - and/or adjuvant or concurrent chemotherapy regimen and
- •(iv)Receiving definitive or adjuvant radiotherapy (dose greater than or equal to 20Gy) encompassing the mediastinum (ie including cardiac structures)
排除标准
- •(i) any contraindication to cardiac MRI (i.e. shrapnel, metallic implants/clips, pacemaker or defibrillator);
- •(ii) severe claustrophobia;
- •(iii) an estimated glomerular filtration rate of less than 50 mL/min/1.732;
- •(iv) pregnancy or breast feeding;
- •(v) documented distant metastases from their known primary cancer;
- •(vi) patients receiving cancer treatment with palliative intent
- •(vii) planned or current use of other targeted biological therapies that can potentially cause cardiotoxicity (i.e. lapatinib)
- •(viii) Pre-existing symptomatic Heart Failure (NYHA Class III or IV).
- •(ix) Recent acute coronary syndrome (myocardial infarction, unstable angina) within the last six months
- •(x) Recent coronary revascularization (percutaneous coronary intervention or coronary bypass surgery) within six months
- •(xi) Permanent atrial fibrillation
- •(xii) Prosthetic breast implants that preclude echocardiography examination
研究者
相似试验
招募中
不适用
Cardiac magnetic resonance imaging and Echocardiogram to investigate myocardial structural and functional changes in patients undergoing irradiation for left sided breast cancer with or without Deep Inspiration Breath HoldCardiovascular diseaseCancer - BreastCardiovascular - Other cardiovascular diseasesBreast cancerACTRN12618001303235Princess Alexandra Hospital40
已完成
不适用
Potential Ability of Cardiac MRI to Predict Efficacy after Cardiac Resynchronization TherapyHeart failureJPRN-UMIN000036415Tokai University Hospital130
已完成
不适用
Cardiovascular Magnetic resonance imaging and Echocardiography in Rheumatoid Arthritis - Patterns of cardiovascular dysfunction in patients with rheumatoid arthritisRArheumatics1008220610023213NL-OMON39670Medisch Spectrum Twente80
招募中
不适用
Cardiac Magnetic Resonance and Computed Tomography First in Suspected Non-ST-Elevation Myocardial Infarction. An Observational Two-Center StudyNL-OMON54580Medisch Universitair Ziekenhuis Maastricht127
招募中
不适用
The usefulness of cardiac MRI for evaluating myocardial fibrosis (modified T1 mapping)cardiomyopathy, diastolic dysfunction, myocardial infarctionJPRN-UMIN000013057Takeshi Adachi50
